Most importantly, this study investigated whether chemotherapy-induced MRP1 regulation can be inhibited with potential therapeutics, using a luminal breast cancer cell line (in accordance with the bias noted by Gonzalez-Angulo et al. to non-basal cancers) and an immortalised non-cancer breast epithelial line. This evidence concerns the gene ABCC1 and breast cancer.